The Newsroom
Deals·October 21, 2026 at 7:25 AM EDT·6 sources

Abbott Plans to Spin Off Its Nutrition Business

ABT +1.2%GS
ABT · last 30 trading days+1.2% since the news
News
Abbott sales after separationapproximately $42 billion
Nutrition annual salesapproximately $8.5 billion

What happened

  • Abbott intends to separate its global Nutrition business into an independent, publicly traded company distributed to Abbott shareholders.
  • The Nutrition company is expected to have approximately $8.5 billion in annual sales and brands including Ensure, PediaSure, Glucerna, Similac and Pedialyte.
  • Abbott expects to complete the separation by the end of 2027, subject to regulatory approvals, a Form 10 registration statement and final board approval.
Nutrition annual sales
approximately $8.5 billion
Abbott sales after separation
approximately $42 billion
Expected completion
by the end of 2027
Nutrition employees
about 16,000

Why it matters

The planned spin-off would create a separately traded nutrition company while leaving Abbott focused on medical devices, diagnostics and established medicines. It is relevant to healthcare investors and corporate-finance professionals assessing portfolio focus, capital allocation and separation execution.

What to watch. Regulatory approvals, effectiveness of the Form 10 registration statement, final Abbott board approval and completion by the end of 2027.

Deal terms

spin off
Abbott Nutrition business
Value
—
Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

Timeline

  1. EarlierOct 18
    Tokenized stock trading takes off overseas as Goldman, other U.S. companies object
  2. EarlierOct 19
    Indonesian Stocks Tumble to Lowest Since 2020 After MSCI Warning
  3. EarlierOct 21
    Goldman Sachs Says War Spurs Sevenfold Jump in Oil Freight Rates
  4. First reported by PR NewswireOct 21
    Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
  5. Bloomberg reportsOct 21
    Abbott Plans to Spin Off Its Nutrition Business
  6. The Wall Street Journal reportsOct 21
    Abbott to Carve Out Nutrition Business Into Independent Company
  7. Financial Times reportsOct 21
    Abbott to spin off nutrition unit at centre of baby formula lawsuits
  8. MedTech Dive reportsOct 21
    Abbott plans to spin out its nutrition business
  9. Food Dive reportsOct 21
    Abbott plans to spin out its nutrition business

Who is involved

Abbott Plans to Spin Off Its Nutrition BusinessAbbott Nutrition businesstargetGoldman Sachs & Co. LLCGSWachtell, Lipton, Rosen & KatzAbbott LaboratoriesABTDaniel Salvadori
CompanyAdvisorPerson

Sources (6)

  1. PR NewswireOct 21
    Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
  2. BloombergOct 21
    Abbott Plans to Spin Off Its Nutrition Business
  3. The Wall Street JournalOct 21
    Abbott to Carve Out Nutrition Business Into Independent Company
  4. Financial TimesOct 21
    Abbott to spin off nutrition unit at centre of baby formula lawsuits
  5. MedTech DiveOct 21
    Abbott plans to spin out its nutrition business
  6. Food DiveOct 21
    Abbott plans to spin out its nutrition business

Related

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

  • Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
  • Follow developing storiesAn alert, and a push, the moment a story you follow moves.
  • Your briefing, read aloudA few minutes each morning with a chapter per story.
  • Brief modeSwipe through the day, a 20-second card each.